Literature DB >> 2787612

Pancytopenia and methotrexate with trimethoprim-sulfamethoxazole.

M E Jeurissen, A M Boerbooms, L B van de Putte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787612     DOI: 10.7326/0003-4819-111-3-261_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.

Authors:  Navtej Sathi; Julie Dawson
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

2.  Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur.

Authors:  Jessica Cudmore; Matthew Seftel; Jeffrey Sisler; Ryan Zarychanski
Journal:  Can Fam Physician       Date:  2014-01       Impact factor: 3.275

Review 3.  Pharmacological therapy for Wegener's granulomatosis.

Authors:  Eric S White; Joseph P Lynch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Use of methotrexate in older patients. A risk-benefit assessment.

Authors:  S E Tett; E J Triggs
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

Review 5.  Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.

Authors:  Jirí Grim; Jaroslav Chládek; Jirina Martínková
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 7.  Clinically important drug interactions with disease-modifying antirheumatic drugs.

Authors:  C J Haagsma
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 4.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.